Hudson Pharma – Shaping the Future of Healthcare with Innovation
Founded in 2010, Hudson Pharma has become a leader in providing cutting-edge pharmaceutical products to both domestic and international markets. Operating out of Karachi, Pakistan, our mission is to make the latest generation treatments accessible to patients, while ensuring safety, efficacy, and affordability.
Commitment to Safety and Quality
At Hudson Pharma, safety is our top priority. The company employs automated manufacturing processes designed to prevent exposure of treatments to both the environment and manufacturing staff. Additionally, all ingredients and inputs for sterile products are sourced exclusively from U.S. FDA or EMA-approved sources, ensuring the highest standards of quality and safety.
Innovative Product Pipeline
Hudson Pharma’s innovation-focused strategy has led to the launch of over 15 first-to-market treatments across the countries it serves. The majority of our business stems from innovative products, and we expect this strength to continue, given our robust R&D pipeline that aims to double the number of first-to-market treatments in our portfolio by the end of 2021.
Advanced Manufacturing Capabilities
Hudson Pharma’s state-of-the-art manufacturing facility in Karachi utilizes Blow Fill Seal (BFS) technology to produce injectables, oral liquids, and respules in polyethylene containers. This fully automated process minimizes human intervention, enhancing product safety and quality. The company also has dedicated manufacturing lines for ophthalmic and dermatological products, ensuring specialized care in these therapeutic areas.
Our Product Portfolio
Hudson Pharma offers a diverse range of pharmaceutical products designed to meet the needs of patients across various therapeutic areas:
- Vydee (Cholecalciferol): A high-dose vitamin D supplement for addressing deficiencies.
- Combihale (Ipratropium Bromide + Salbutamol): A combination inhaler for asthma and COPD management.
- Xaleve (Ibuprofen): An injectable form of ibuprofen for pain and inflammation.
- Levhale (Levalbuterol HCl): A bronchodilator for respiratory conditions.
- Recuro (Carboxymethylcellulose): An eye drop solution for dry eye relief.
- Teardrop (Polyethylene Glycol + Propylene Glycol): Eye drops for moisture and lubrication.
- Easehale (Ipratropium Bromide): A nasal spray for respiratory conditions.
- Ferris (Iron Sucrose): An injectable iron supplement for iron-deficiency anemia.
- Moxiopt (Moxifloxacin): An ophthalmic solution for bacterial eye infections.
- Respy (Tiotropium Bromide): A bronchodilator for chronic respiratory conditions.
- Torason (Ketorolac Tromethamine): An injectable NSAID for pain management.
- Travson (Travoprost): An eye drop solution for glaucoma.
- Brimson (Brimonidine Tartrate): An eye drop solution for ocular hypertension.
- Brimson Plus (Brimonidine Tartrate + Timolol Maleate): A combination eye drop solution for glaucoma.
- Optidine (Olopatadine): An eye drop solution for allergic conjunctivitis.
- Nepopt (Nepafenac): An eye drop solution for inflammation and pain.
- Amak (Amikacin Sulfate): An injectable antibiotic for bacterial infections.
Global Presence
Hudson Pharma exports its products to various international markets, contributing to global healthcare solutions. The company’s robust distribution network ensures that its products are readily available in both domestic and international markets.
Contact Hudson Pharma
For more information about Hudson Pharma’s products and services, visit our official website: https://www.hudsonpharma.com